402 related articles for article (PubMed ID: 27366224)
1. Epigenetic therapy in gastrointestinal cancer: the right combination.
Abdelfatah E; Kerner Z; Nanda N; Ahuja N
Therap Adv Gastroenterol; 2016 Jul; 9(4):560-79. PubMed ID: 27366224
[TBL] [Abstract][Full Text] [Related]
2. Targeting Chromatin Remodeling for Cancer Therapy.
Kaur J; Daoud A; Eblen ST
Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
[TBL] [Abstract][Full Text] [Related]
3. Cancer epigenetics: new therapies and new challenges.
Hatzimichael E; Crook T
J Drug Deliv; 2013; 2013():529312. PubMed ID: 23533770
[TBL] [Abstract][Full Text] [Related]
4. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
5. Advances in Epigenetic Cancer Therapeutics.
Hillyar C; Rallis KS; Varghese J
Cureus; 2020 Nov; 12(11):e11725. PubMed ID: 33391954
[TBL] [Abstract][Full Text] [Related]
6. Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg.
Fernández-Barrena MG; Arechederra M; Colyn L; Berasain C; Avila MA
JHEP Rep; 2020 Dec; 2(6):100167. PubMed ID: 33134907
[TBL] [Abstract][Full Text] [Related]
7. The role of epigenetic therapies in colorectal cancer.
Baretti M; Azad NS
Curr Probl Cancer; 2018 Nov; 42(6):530-547. PubMed ID: 29625794
[TBL] [Abstract][Full Text] [Related]
8. CpG Island Methylator Phenotype-A Hope for the Future or a Road to Nowhere?
Paweł K; Maria Małgorzata S
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055016
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Regulation in Oral Squamous Cell Carcinoma Microenvironment: A Comprehensive Review.
Mesgari H; Esmaelian S; Nasiri K; Ghasemzadeh S; Doroudgar P; Payandeh Z
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067304
[TBL] [Abstract][Full Text] [Related]
10. Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas.
Fennell L; Dumenil T; Wockner L; Hartel G; Nones K; Bond C; Borowsky J; Liu C; McKeone D; Bowdler L; Montgomery G; Klein K; Hoffmann I; Patch AM; Kazakoff S; Pearson J; Waddell N; Wirapati P; Lochhead P; Imamura Y; Ogino S; Shao R; Tejpar S; Leggett B; Whitehall V
Cell Mol Gastroenterol Hepatol; 2019; 8(2):269-290. PubMed ID: 30954552
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
Chistiakov DA; Orekhov AN; Bobryshev YV
Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation and cancer (review).
Chen QW; Zhu XY; Li YY; Meng ZQ
Oncol Rep; 2014 Feb; 31(2):523-32. PubMed ID: 24337819
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics and therapeutic targets in gastrointestinal malignancies.
Nagaraju GP; Kasa P; Dariya B; Surepalli N; Peela S; Ahmad S
Drug Discov Today; 2021 Oct; 26(10):2303-2314. PubMed ID: 33895313
[TBL] [Abstract][Full Text] [Related]
14. Epigenetics as a therapeutic target in breast cancer.
Connolly R; Stearns V
J Mammary Gland Biol Neoplasia; 2012 Dec; 17(3-4):191-204. PubMed ID: 22836913
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Priming and Development of New Combination Therapy Approaches.
Meneceur S; Grunewald CM; Niegisch G; Hoffmann MJ
Methods Mol Biol; 2023; 2684():259-281. PubMed ID: 37410240
[TBL] [Abstract][Full Text] [Related]
16. Direct monitoring of breast and endometrial cancer cell epigenetic response to DNA methyltransferase and histone deacetylase inhibitors.
Teixeira SR; Abreu CM; Parkes L; Davies J; Yao S; Sawhney MA; Margarit L; Gonzalez D; Pinto IM; Francis LW; Conlan RS
Biosens Bioelectron; 2019 Sep; 141():111386. PubMed ID: 31220725
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors.
Schneider-Stock R; Ocker M
IDrugs; 2007 Aug; 10(8):557-61. PubMed ID: 17665331
[TBL] [Abstract][Full Text] [Related]
18. Chemical Tools with Fluorescence Switches for Verifying Epigenetic Modifications.
Hori Y; Kikuchi K
Acc Chem Res; 2019 Oct; 52(10):2849-2857. PubMed ID: 31577127
[TBL] [Abstract][Full Text] [Related]
19.
Jahan Z; Benthani FA; Currey N; Parker HW; Dahlstrom JE; Caldon CE; Kohonen-Corish MRJ
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740525
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy.
Wagner JM; Hackanson B; Lübbert M; Jung M
Clin Epigenetics; 2010 Dec; 1(3-4):117-136. PubMed ID: 21258646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
